Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception
Description
BACKGROUND: The novel coronavirus disease (COVID-19) has led to significant mortality and morbidity, including a high incidence of related thrombotic events. There has been concern regarding hormonal contraception use during the COVID-19 pandemic, as
